Pritelivir mesylate
CAS: 1428333-96-3
Ref. 3D-BP180891
| 5mg | 136.00 € | ||
| 10mg | 192.00 € | ||
| 25mg | 271.00 € | ||
| 50mg | 406.00 € | ||
| 100mg | 592.00 € |
Product Information
Pritelivir is a prodrug that is converted to the active form, pritelivir mesylate, in vivo. It has antiviral activity against viruses such as herpes simplex virus type 1 and type 2 (HSV-1, HSV-2) and cytomegalovirus (CMV). Pritelivir has been shown to be safe and well tolerated in clinical trials for both men and women with genital herpes. Pritelivir mesylate is administered orally as tablets or capsules. The drug has also been formulated as a solubilized preparation for intravenous administration. Pritelivir mesylate has been designed to maximise absorption by using maleic acid salts instead of salts of other acids.
Pritelivir mesylate is not yet approved for use but the company expects it to be available soon.
Chemical properties
Technical inquiry about: 3D-BP180891 Pritelivir mesylate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
